Chapter 1: The Foundation of Pharmacology: Quality and Safety Flashcards
Brand (Trade) Name
Manufacturer’s chosen name for a drug, which is protected by a patent
Controlled substances
Drugs that are categorized by federal law according to therapeutic usefulness and potential for abuse; scheduled drugs
Drug classifications
Medications grouped according to their effects on particular body systems, therapeutic uses and chemical characteristics
Generic Name
Chemical of official name of the drug that is independent of the manufacturer and often indicates the drug group
OTC drugs
Medications available without a prescription
Pharmacoeconomics
Cost of drug therapy, dispensing, administration, lab tests; consider losses due to expiration
Pharmacogenomics
Study of how a person’s genetic heritage leads to variable responses to drugs
Prototype
Often the first drug of a particular drug class to be developed; usually standard against which newer, similar drugs are compared
Pharmacotherapy
Use of drugs to prevent, diagnose, or treat signs, symptoms, and disease processes
Controlled substances: schedule I
No accepted medical use, lack of accepted safety, high abuse potentials (heroin, LSD, MDMA, Mescaline, peyote)
Controlled Substances: Schedule II
Drugs that are used medically but have high abuse potentials (opioid analgesics, CNS stimulants, barbiturate sedative-hypnotics)
Controlled Substances: Schedule III
Drugs with less potential for abuse than those in schedules I/II, but abuse of which may lead to psychological or physical dependence (androgens, anabolic steroids, some depressants, CNS stimulants and mixtures containing small amounts of controlled substances)
Controlled substances: Schedule IV
Drugs with an accepted medical use in the US but with some potential for abuse (benzodiazepines, other sedative-hypnotics and some appetite suppressants
Controlled Substances: Schedule V
Products contains moderate amounts of controlled substances. They may be dispensed by the pharmacist without a physician’s prescription but with some restrictions regarding amount, record keeping and other safeguards. (Cough suppressants, antidiarrheal drugs)
Clinical trial five phases
Phase 0: drug testing occurs in animals and small groups of humans
Phase one: doses are given to a certain number of healthy volunteers (determine safe dosages, routes of administration, absorption, metabolism, excretion and toxicity)
Phase two: few doses are given to a certain number of subjects with the disease or symptoms for which the drug is being studied
Phase three: the drug is given to different populations and different dosages; do double blind placebo studies
Phase four: the FDA allows the drug to be marketed and requires manufacturers to continue post-marketing monitoring